Publications - 'P'
Publications 1901 - 1925 de 2458
| Titre | DOI |
|---|---|
|
Profiles of caregivers most at risk of having unmet supportive care needs: Recommendations for healthcare professionals in oncology A.S. Baudry; L. Vanlemmens; A. Anota; A. Cortot; G. Piessen; V. Christophe 2019 |
10.1016/j.ejon.2019.09.010 |
|
Profiles of volatile organic compound emissions from soils amended with organic waste products L. Abis; B. Loubet; R. Ciuraru; F. Lafouge; S. Dequiedt; S. Houot; P.Alain Maron; S. Bourgeteau-Sadet 2018 |
10.1016/j.scitotenv.2018.04.232 |
|
Profiling farming management strategies with contrasting pesticide use in France M. Lechenet; D. Makowski; G. Py; N. Munier-Jolain 2016 |
10.1016/j.agsy.2016.08.005 |
|
Profiling Immune Escape in Hodgkin's and Diffuse large B-Cell Lymphomas Using the Transcriptome and Immunostaining S. Pericart; M. Tosolini; P. Gravelle; C. Rossi; A. Traverse-Glehen; N. Amara; C. Franchet; E. Martin; C. Bezombes; G. Laurent; P. Brousset; J.J. Fournie; C. Laurent 2018 |
10.3390/cancers10110415 |
|
Profit, morality and discrimination M. Bunel; E. Tovar 2021 |
10.1080/00036846.2021.1907285 |
|
Profound and Sustained Response with ALK Inhibitors in Patients with CNS Relapse or Progressive ALK- Positive Anaplastic Lymphoma C. Rigaud; R. Abbas; M. Simonin; L. Le Mouel; V. Peraira; V. Minard-Colin; B. Geoerger; L. Brugieres 2019 |
|
|
PROfound: A randomized Phase III trial evaluating olaparib in patients with metastatic castration-resistant prostate cancer and a deleterious homologous recombination DNA repair aberration. J.S. De Bono; M. Hussain; A. Thiery-Vuillemin; J. Mateo; O. Sartor; K.N. Chi; K. Fizazi; P. Twardowski; N. Agarwal; S.Kaur Sandhu; D. Olmos; N.D. Shore; F. Saad; S. Liu; C.Dietrich Goessl; J. Burgents 2017 |
10.1200/JCO.2017.35.15_suppl.TPS5091 |
|
PROfound: Phase III study of olaparib versus enzalutamide or abiraterone for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations M. Hussain; J. Mateo; K. Fizazi; F. Saad; N.D. Shore; S. Sandhu; K.N. Chi; O. Sartor; N. Agarwal; D. Olmos; A. Thiery-Vuillemin; P. Twardowski; N. Mehra; C. Goessl; J. Kang; J. Burgents; W. Wu; A. Kohlmann; C.A. Adelman; J. de Bono 2019 |
|
|
PROfound: Phase III study of olaparib versus enzalutamide or abiraterone for metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations S.K. Sandhu; M. Hussain; J. Mateo; K. Fizazi; F. Saad; N. Shore; K. Chi; O. Sartor; N. Agarwal; D. Olmos; A. Thiery-Vuillemin; P. Twardowski; N. Mehra; C. Goessl; J. Kang; J. Burgents; W. Wu; A. Kohlmann; C. Adelman; J. de Bono 2019 |
|
|
Profound: Phase III Study of the Efficacy and Safety of Olaparib versus Enzalutamide or Abiraterone Acetate in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Homologous Recombination Repair Gene (HRR) Alterations S. Feyerabend; M. Hussain; J. Mateo; K. Fizazi; F. Saad; N. Shore; S. Sandhu; K. Chi; O. Sartor; N. Agarwal; D. Olmos; A. Thiery-Vuillemin; P. Twardowski; N. Mehra; C. Goessl; J. Kang; J. Burgents; W. Wu; A. Kohlmann; C. Adelman; J. de Bono 2020 |
|
|
PROfound: Phase III study of the efficacy and safety of olaparib versus enzalutamide or abiraterone acetate in men with metastatic castration-resistant prostate cancer (mCRPC) and homologous recombination repair gene mutations (HRRm) S. Sandhu; M. Hussain; J. Mateo; K. Fizazi; F. Saad; N. Shore; K. Chi; O. Sartor; N. Agarwal; D. Olmos; A. Thiery-Vuillemin; P. Twardowski; N. Mehra; C. Goessl; J. Kang; J. Burgents; W. Wu; A. Kohlmann; C. Adelman; J. de Bono 2019 |
|
|
Proglacial sediment dynamics from daily to seasonal scales in a glaciated Alpine catchment (Bossons glacier, Mont Blanc massif, France) H. Guillon; J.L. Mugnier; J.F. Buoncristiani 2018 |
10.1002/esp.4333 |
|
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study D. Tougeron; B. Sueur; A. Zaanan; C. de la Fouchardiere; D. Sefrioui; T. Lecomte; T. Aparicio; G.Des Guetz; P. Artru; V. Hautefeuille; R. Coriat; V. Moulin; C. Locher; Y. Touchefeu; C. Lecaille; G. Goujon; A. Ferru; C. Evrard; R. Chautard; L. Gentilhomme; D. Vernerey; J. Taieb; T. Andre; J. Henriques; R. Cohen; A.Gastroent Oncologu 2020 |
10.1002/ijc.32879 |
|
Prognosis and chemosensitivity of non-V600E BRAF mutations in metastatic colorectal carcinoma (mCRC): An AGEO French multicenter retrospective cohort. A. Derosiere; V. Nicolai; D. Malka; A. Pozet; J. Lazartigues; A. Turpin; D. Tougeron; T. Walter; P. Artru; J.B. Bachet; J.Marc Phelip; C. Lepage; A. Lievre; M. Caulet; E. Norguet; N. Lourenco; R. Coriat; D. Sefrioui; J. Dremaux; V. Hautefeuille 2019 |
10.1200/JCO.2019.37.15_suppl.3575 |
|
Prognosis factors in malignant ovarian germ cell tumors (MOGCT): retrospective analysis of 147 cases prospectively included in the French network for Rare Malignant Ovarian Tumors (TMRO) & GINECO group F. Derquin; A. Floquet; J.Pierre Lotz; J. Edeline; J. Alexandre; P. Pautier; G. Ferron; S. Oudard; C.Lefeuvre Plesse; H. Vegas; A. Patsouris; E. Kalbacher; D.Berton Rigaud; A.Claire Har Bessard; V. Lavoue; I. Treilleux; I.Ray Coquard; T.De la Mott Rouge 2018 |
|
|
Prognosis factors in malignant ovarian germ cell tumors (MOGCT): retrospective analysis of 147 cases prospectively included in the French network for Rare Malignant Ovarian Tumors (TMRO) & GINECO group F. Derquin; A. Floquet; J.Pierre Lotz; J. Edeline; J. Alexandre; P. Pautier; G. Ferron; S. Oudard; C.Lefeuvre Plesse; H. Vegas; A. Patsouris; E. Kalbacher; D.Berton Rigaud; A.Claire Har Bessard; V. Lavoue; I. Treilleux; I.Ray Coquard; T.De la Mott Rouge 2018 |
|
|
Prognosis factors influencing three-month respiratory outcomes in intensive care unit survivors after COVID-19 pneumonia S. Karaer; G. Eberst; F. Claude; L. Laurent; A. Meurisse; P. Roux-Claude; C. Barnig; K. Bouiller; C. Chirouze; J. Behr; F. Grillet; O. Ritter; S. Pili-Floury; H. Winiszewski; E. Samain; G. Capellier; V. Westeel 2021 |
10.1183/13993003.congress-2021.PA897 |
|
Prognosis in patients with atrial fibrillation and a presumed ``temporary cause'' in a community-based cohort study L. Fauchier; N. Clementy; A. Bisson; K. Stamboul; F. Ivanes; D. Angoulvant; D. Babuty; G.Y.H. Lip 2017 |
10.1007/s00392-016-1040-7 |
|
Prognosis model for overall survival in locally advanced pancreatic cancer (LAPC): An ancillary study of the LAP 07 trial. D. Vernerey; P. Hammel; S. Paget-Bailly; F. Huguet; J.Luc Van Laethem; D. Goldstein; B. Glimelius; P. Artru; M. Moore; T. Andre; L. Mineur; B. Chibaudel; C. Louvet; F. Bonnetain 2014 |
10.1200/jco.2014.32.15_suppl.4024 |
|
Prognosis model for overall survival in locally advanced unresecable pancreatic carcinoma: An ancillary study of the LAP 07 trial D. Vernerey; P. Hammel; S. Paget-Bailly; F. Huguet; J.Luc Van Laethem; D. Goldstein; B. Glimelius; P. Artru; M.J. Moore; T. Andre; L. Mineur; B. Chibaudel; C. Louvet; F. Bonnetain 2015 |
10.1200/jco.2015.33.3_suppl.235 |
|
Prognosis of acute kidney injury during acute heart failure: the role of diuretics Y. Lombardi; F. Boccara; K. Baldet; S. Lang; S. Ederhy; P. Nhan; Q. Riller; M. Chauvet-Droit; M.L. Jean; S. Adavane-Scheuble; L. Azoyan; A. Cohen 2020 |
|
|
Prognosis of acute kidney injury during acute heart failure: the role of diuretics Y. Lombardi; F. Boccara; K. Baldet; S. Lang; S. Ederhy; P. Nhan; Q. Riller; M. Chauvet-Droit; M.L. Jean; S. Adavane-Scheuble; L. Azoyan; A. Cohen 2020 |
|
|
Prognosis of Alf of Unknown Cause: Results of the French Multicentre Prospective Hasipro Study A. Coilly; S. Dharancy; C. Duvoux; J.P. Cervoni; J. Dumortier; S. Radenne; L. Alric; C. Besch; C. Francoz; J.Marc Perarnau; M. Rudler; N. Carbonell; C. Silvain; V. Leroy; A.Vallet Pichard; G. Lassailly; F. Artru; T. Antonini; H. Agostini; C. Piedvache; J.Charles Du Vallee; P. Ichai; D. Samuel 2018 |
|
|
Prognosis of ALF of unknown cause: results of the French multicentre prospective HASIPRO study C. Audrey; S. Dharancy; C. Duvoux; V. Di Martino; J. Dumortier; S. Radenne; L. Alric; C. Besch; C. Francoz; J. Perarnaud; M. Rudler; N. Carbonell; C. Silvain; V. Leroy; A. Vallet-Pichard; G. Lassailly; F. Artru; T. Antonini; H. Agostini; C. Piedvache; J.C. Duclos-Vallee; P. Ichai; D. Samuel 2018 |
|
|
Prognosis of ALF of unknown cause: results of the French multicentre prospective HASIPRO study A. Coilly; S. Dharancy; C. Duvoux; V.D. Martino; J. Dumortier; S. Radenne; L. Alric; C. Besch; C. Francoz; J. Perarnaud; M. Rudler; N. Carbonell; C. Silvain; V. Leroy; A.V. Pichard; G. Lassailly; F. Artru; T. Antonini; H. Agostini; C. Piedvache; J.C. Duclos-Vallee; P. Ichai; D. Samuel 2018 |
10.1016/S0168-8278(18)30357-X |